ArticleBlood2026
Ziftomenib with venetoclax and azacitidine for relapsed/refractory NPM1-mutated acute myeloid leukemia.
Eunice S Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleBlood2026
Eunice S Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.